Skip to main content

Early trial results show promise for J&J and Beth Israel vaccine

By WBUR  
   September 29, 2020

Researchers have reported hopeful results from an early clinical trial of a potential coronavirus vaccine developed by a team from from Beth Israel Deaconess Medical Center and Johnson & Johnson. The company announced earlier this week it has moved forward to field test what could be a the first single-shot vaccine for the virus in a third and final phase clinical trial.

Full story


Get the latest on healthcare leadership in your inbox.